95-13209. Advisory Committee on Immunization Practices; Meeting  

  • [Federal Register Volume 60, Number 104 (Wednesday, May 31, 1995)]
    [Notices]
    [Page 28413]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-13209]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    
    
    Advisory Committee on Immunization Practices; Meeting
    
        In accordance with section 10(a)(2) of the Federal Advisory 
    Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
    Prevention (CDC) announces the following committee meeting:
    
        Name: Advisory Committee on Immunization Practices (ACIP).
        Times and Dates: 8:30 a.m.-6 p.m., June 28, 1995; 8:15 a.m.-3:30 
    p.m., June 29, 1995.
        Place: CDC, Auditorium A, Building 2, 1600 Clifton Road, NE, 
    Atlanta, Georgia 30333.
        Status: Open to the public, limited only by the space available.
        Purpose: The committee is charged with advising the Director, 
    CDC, on the appropriate uses of immunizing agents.
        Matters to be discussed: The committee will discuss the polio 
    vaccine policy; the approach to developing ACIP vaccine 
    recommendations; hepatitis A vaccine--use in high endemic 
    populations; varicella update; ``Vaccines for Children Program'': 
    Hepatitis A, hepatitis B, varicella; adolescent immunization visit; 
    measles elimination update; vaccine safety update: preference of 
    DTaP for 4th and 5th doses; ACIP participation in the National 
    Vaccine Advisory Committee and the Advisory Commission on Childhood 
    Vaccines Subcommittee on Vaccine Safety; measles vaccine 
    inflammatory bowel disease; large-linked database (LLDB) results; 
    acellular pertussis vaccine trial results; programmatic strategies 
    to increase immunization coverage; pneumococcal conjugate vaccine; 
    harmonization of immunization recommendations; update on progress 
    towards disease elimination goals; ACIP recommendations and package 
    inserts; diphtheria and the New Independent States update: the U.S. 
    contingency plan; electronic updating of ACIP recommendations; an 
    Injury Compensation Program update; and a National Vaccine Program 
    update. Other matters of relevance among the committee's objectives 
    may be discussed.
        Agenda items are subject to change as priorities dictate.
        Contact person for more information: Gloria A. Kovach, Committee 
    Management Specialist, CDC (1-B72), 1600 Clifton Road, NE, Mailstop 
    A20, Atlanta, Georgia 30333, telephone 404/639-3851.
    
        Dated: May 24, 1995.
    Carolyn J. Russell,
    Director, Management Analysis and Services Office, Centers for Disease 
    Control and Prevention (CDC).
    [FR Doc. 95-13209 Filed 5-30-95; 8:45 am]
    BILLING CODE 4163-18-M
    
    

Document Information

Published:
05/31/1995
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
95-13209
Dates:
8:30 a.m.-6 p.m., June 28, 1995; 8:15 a.m.-3:30 p.m., June 29, 1995.
Pages:
28413-28413 (1 pages)
PDF File:
95-13209.pdf